OpenAlex
PricingAboutJobs
Log inGet started
Work

Pexacerfont as a CRF1 antagonist for the treatment of withdrawal symptoms in men with heroin/methamphetamine dependence: a randomized, double-blind, placebo-controlled clinical trial

HTML

Year: 2017
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: International Clinical Psychopharmacology
DOI: 10.1097/yic.0000000000000200
Authors: Mohammad-Javad Morabbi, Emran Razaghi, Ehsan Moazen-Zadeh, Hamideh Safi-Aghdam, Mohamad R. Zarrindast, Nasim Vousoghi, Shahin Akhondzadeh
Institutions: Roozbeh Hospital, Tehran University of Medical Sciences
Language: English

Topic: Opioid Use Disorder Treatment
Subfield: Public Health, Environmental and Occupational Health
Field: Medicine
Domain: Health Sciences
Keywords: CRF1 receptor antagonist, heroin addiction, methamphetamine dependence, drug withdrawal symptoms, craving, opioid withdrawal, amphetamine withdrawal, temptation, anxiety, depression, urine drug testing
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2765215453
FWCI: 3.257
Cites: 29
Cited by: 34
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security